ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,639, issued on May 27, was assigned to i2Dx Inc. (San Francisco).
"Alzheimer's disease personalized medicine" was invented by Janos Redei (San Francisco).
According to the abstract* released by the U.S. Patent & Trademark Office: "According to an aspect of an embodiment, a method for detection of at least one single nucleotide polymorphism (SNP) in a human subject from assaying a combination of SNPs can include: a) obtaining a nucleic acid sample from said human subject; b) genotyping the sample for a combination of Alzheimer's disease associated genes(s) RTTN, ALCAM/CD166, DMXL2, and DYNLL1, said combination of SNP alleles being the following: rs4891826 (G), rs2030515 (G), rs716...